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Abstract 
A serological survey was carried out to investigate the presence of 
avian influenza (AI) antibodies in Khartoum state. 
         A total of 190 serum samples were collected from chickens 
from different farms in Khartoum state. The serum samples consisted of 
73 sera collected from broiler chicken and 117 sera from layer chicken. 
Ten serum samples were collected from poultry workers at these farms. 
The sera were tested by agar gel immunodiffusion (AGID) test, the 
results showed that 51 sera out of 73(69.9) from broiler were positive 
and 56 sera out of 117 (47.9) from layer were positive for AI. 
        The results of testing sera collected from poultry laborers by AGID 
showed that 7out of 10 (70%) sera were positive for AI. The hem 
agglutination inhibition (HI) test was applied to the same sera which 
were positive by AGID test for sub typing the antibodies using H5N1 
and H7N3 antigens. The results of sera collected from layer chickens 
when tested against H7N3 antigen revealed that 14 out of 34(41.2%) sera 
were positive from Khartoum North area and 4 out of 22 (18.2%) sera 
were positive from Khartoum area. The results of testing sera from 
broiler chickens using the same antigen showed that only three serum 
samples were positive from Khartoum North area and there are no 
positive sera from Omdurman area. The sera when tested against H5N1 
revealed that only one serum sample is positive from layer chicken from 
Khartoum area. The results of testing sera collected from poultry 
laborers by HI test showed that 4 out of 7 (57.1%) sera were positive 
against H7N3 antigen, when the same sera were tested against H5N1 
antigen the results revealed that no antibodies were detected in humans     
 اﻟﺨﻼﺻﺔ
  
ﻤﺴﺢ ﻤﺼﻠﻲ ﺍﺠﺭﻱ ﻟﻠﺒﺤﺙ ﻋﻥ ﻭﺠﻭﺩ ﺃﺠﺴﺎﻡ ﻤﻀﺎﺩﺓ ﻷﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ ﻓﻲ ﻭﻻﻴﺔ 
 ﺠﻤﻌﺕ ﻤﻥ ﺍﻟﺩﻭﺍﺠﻥ ﻤﻥ ﻤﺨﺘﻠـﻑ ﺍﻟﻤـﺯﺍﺭﻉ ﻓـﻲ   ﻋﻴﻨﺔ ﺴﻴﺭﻡ 091ﻤﺠﻤﻭﻉ . ﺍﻟﺨﺭﻁﻭﻡ
 ﺴﻴﺭﻡ 711 ﺴﻴﺭﻡ ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﻼﺤﻡ ﻭ 37ﻋﻴﻨﺎﺕ ﺍﻟﺴﻴﺭﻡ ﺘﺤﺘﻭﻱ ﻋﻠﻲ . ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ 
ﻫﺫﻩ .  ﻋﻴﻨﺎﺕ ﺴﻴﺭﻡ ﺠﻤﻌﺕ ﻤﻥ ﻋﻤﺎل ﺍﻟﺩﻭﺍﺠﻥ ﻓﻲ ﺘﻠﻙ ﺍﻟﻤﺯﺍﺭﻉ 01. ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ 
  . ﺍﻟﻌﻴﻨﺎﺕ ﻓﺤﺼﺕ ﺒﺎﺨﺘﺒﺎﺭ ﺍﻻﻨﺘﺸﺎﺭ ﺍﻟﻤﻨﺎﻋﻲ ﻓﻲ ﻫﻼﻡ ﺍﻟﺠل
 ﺴـﻴﺭﻡ ﻤـﻥ 65 ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﻼﺤﻡ ﻤﻭﺠﺒﻪ ﻭ 37ﺭﻡ ﻤﻥ ﻤﺠﻤﻭﻉ  ﺴﻴ 15ﺍﻟﻨﺘﺎﺌﺞ ﺃﻅﻬﺭﺕ 
 ﺕﺍﻟﻨﺘـﺎﺌﺞ ﻟﻠـﺴﻴﺭﻤﺎ .  ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ ﻤﻭﺠﺒـﻪ ﻷﻨﻔﻠـﻭﻨﺯﺍ ﺍﻟﻁﻴـﻭﺭ 711ﻤﺠﻤﻭﻉ 
 ﺍﻟﻤﻨﺎﻋﻲ ﻓﻲ ﻫـﻼﻡ ﺍﻟﺠـل ﺭﺍﻟﻤﻔﺤﻭﺼﺔ ﺍﻟﺘﻲ ﺠﻤﻌﺕ ﻤﻥ ﻋﻤﺎل ﺍﻟﺩﻭﺍﺠﻥ ﺒﻭﺍﺴﻁﺔ ﺍﻻﻨﺘﺸﺎ 
ﺜﺒـﻴﻁ ﺍﺨﺘﺒﺎﺭ ﺘ .  ﻤﻭﺠﺒﻪ ﻷﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ ﺕ ﺴﻴﺭﻤﺎ 01 ﻤﻥ ﻤﺠﻤﻭﻉ ﺕ ﺴﻴﺭﻤﺎ 7ﺃﻅﻬﺭﺕ 
ﺍﻟﺘﻼﺯﻥ ﺍﻟﺩﻤﻭﻱ ﺘﻡ ﺍﺠﺭﺍﺀﻭﻩ ﻟﻨﻔﺱ ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﺔ ﻻﺨﺘﺒﺎﺭ      ﺍﻻﻨﺘﺸﺎﺭ ﺍﻟﻤﻨﺎﻋﻲ ﻓـﻲ 
  3N7H. ﻭ 1N5Hﻫﻼﻡ ﺍﻟﺠل ﻟﺘﺤﺩﻴﺩ ﻨﻭﻉ ﺍﻷﺠﺴﺎﻡ ﺍﻟﻤﻀﺎﺩﺓ ﻤﺴﺘﺨﺩﻤﺎ  ﺍﻨﺘﻴﺠﻨﺎﺕ 
 ﺍﻟﺘﻲ ﺠﻤﻌﺕ ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ ﻋﻨـﺩﻤﺎ ﻓﺤـﺼﺕ ﻀـﺩ ﺍﻻﻨﺘﺠـﻴﻥ ﺕﺍﻟﻨﺘﺎﺌﺞ ﻟﻠﺴﻴﺭ ﻤﺎ 
 ﻤـﻥ 4ﻤﻭﺠﺒﺔ ﻓﻲ ﻤﻨﻁﻘـﺔ ﺒﺤـﺭﻱ ﻭ  ﺴﻴﺭﻡ 42 ﻤﻥ  ﻤﺠﻤﻭﻉ 41  ﺃﻅﻬﺭﺕ   3N7H
  .ﺴﻴﺭﻡ ﻤﻭﺠﺒﺔ ﻓﻲ ﻤﻨﻁﻘﺔ ﺍﻟﺨﺭﻁﻭﻡ22ﻤﺠﻤﻭﻉ 
 ﺍﻟﻤﻔﺤﻭﺼﺔ ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﻼﺤﻡ ﺒﺎﺴﺘﺨﺩﺍﻡ ﻨﻔﺱ ﺍﻻﻨﺘﺠﻴﻥ ﺍﻅﻬﺭﺕ ﺜـﻼﺙ ﺕﺍﻟﻨﺘﺎﺌﺞ ﻟﻠﺴﻴﺭﻤﺎ 
 ﺴﻴﺭﻤﺎﺕ ﻤﻭﺠﺒﺔ ﻓـﻲ ﻤﻨﻁﻘـﺔ ﺍﻡ ﺩﻋﻴﻨﺎﺕ ﺴﻴﺭﻡ  ﻓﻘﻁ ﻤﻭﺠﺒﺔ ﻤﻥ ﻤﻨﻁﻘﺔ ﺒﺤﺭﻱ ﻭﻻ ﺘﻭﺠ 
   .  ﺩﺭﻤﺎﻥ 
ﻴﻨﺔ ﺴﻴﺭﻡ ﻭﺍﺤﺩﻩ ﻓﻘﻁ ﻤﻭﺠﺒـﺔ  ﺃﻅﻬﺭﺕ ﻋ 1N5Hﺍﻟﺴﻴﺭﻤﺎﺕ ﻋﻨﺩﻤﺎ ﻓﺤﺼﺕ ﻀﺩ 
 .ﻤﻥ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺒﻴﺎﺽ ﻓﻲ ﻤﻨﻁﻘﺔ ﺍﻟﺨﺭﻁﻭﻡ
ﺍﻟﻨﺘﺎﺌﺞ ﻟﻠﺴﻴﺭﻤﺎﺕ ﺍﻟﻤﻔﺤﻭﺼﺔ ﺍﻟﺘﻰ ﺠﻤﻌﺕ ﻤﻥ ﻋﻤﺎل ﺍﻟﺩﻭﺍﺠﻥ ﺒﻭﺍﺴﻁﺔ ﺍﺨﺘﺒـﺎﺭ ﺘﺜﺒـﻴﻁ 
  3N7H ﻋﻴﻨﺎﺕ ﻤﻭﺠﺒﺔ ﻀﺩ ﺍﻻﻨﺘﺠﻴﻥ 7 ﻋﻴﻨﺎﺕ ﻤﻥ ﻤﺠﻤﻭﻉ 4ﺃﻅﻬﺭﺕ  ﺍﻟﺘﻼﺯﻥ ﺍﻟﺩﻤﻭﻯ 
ﻬﺭﺕ ﻋـﺩﻡ ﻭﺠـﻭﺩ  ﺍﻟﻨﺘﺎﺌﺞ ﺍﻅ 1N5H  ﻀﺩ ﺍﻻﻨﺘﺠﻴﻥ ﺕﻭﻋﻨﺩﻤﺎ ﻓﺤﺼﺕ ﻨﻔﺱ ﺍﻟﺴﻴﺭﻤﺎ 
 .ﺃﺠﺴﺎﻡ ﻤﻀﺎﺩﺓ
  
  
 
 Introduction 
 
            Avian influenza (AI) is a viral disease causing high infectious 
respiratory disease in mammals including humans and birds (Murphy 
and Webster, 1996).  In recent years influenza viruses are the main 
concern for the poultry industry and also recognized as human health 
concern because of their ability to be transmitted and cause disease direct 
to man (Alexander, 2000; lipatov et al ., 2004). AI virus belongs to the 
family Orthomyxoviridae and placed in the genus influenza A. There are 
three influenza genera A, B and C and only influenza A viruses are 
known to infect birds (OIE, 2004). Influenza viruses can be subtyped 
according to the serological reactivity of their surface antigens 
hemagglutinin (HA) and neuraminidase (NA) gylcoprotiens (Rhom et 
al., 1996). 
            The disease occurs in a wide range of domestic and wild avian 
species such as chicken, turkeys, duck, geese, quail, pheasants, quinea 
fowl, terns, wild ducks and wild geese (Alexander, 1982a). The disease 
may be inapparent, mild or in some instance severe with high mortality, 
depending on factors such as overcrowding, poor ventilation and 
concurrent infection (Quinn et al., 2004). The clinical signs of the 
disease are characterized by decrease in egg production, respiratory 
signs, excessive lacrimation, oedema of the head, diarrhea, neurological 
symptoms and death (Jong and Hien, 2006). Infected birds shed 
influenza virus in their saliva, nasal secretions, and feces. Susceptible 
birds become infected when they have contact with contaminated 
secretions or excretions  from infected birds. Domesticated birds may 
become infected with AI virus through direct contact with infected 
waterfowl or other infected poultry, or through contact with surfaces 
(such as dirt or cages) or materials (such as water or feed) that have been 
contaminated with the virus (Centers for Disease Control and Prevention 
(CDC), 2006). Outbreaks of highly pathogenic avian influenza (HPAI) 
H5N1 virus were initially observed in southern China in 1996 and 1997 
(Claas et al., 1998a; Guan et al., 1999; Xu et al., 1999). The disease  
caused major poultry outbreaks in Vietnam, Thailand, Indonesia and 
other East Asian countries since early 2004 (Li et al., 2004; Vieshakual 
et al., 2004; Tiensin et al., 2005 and WHO, 2005a). The virus is now 
endemic in poultry in these countries and has caused repeated zoonotic 
transmission to humans (Chotpitayasunondh et al., 2005, Hien et al., 
2004 and Puthavathana et al., 2005).          
AI influenza was reported in the Sudan for the first time in 
1925(Annual report of the Sudan veterinary service, 1925). It was until 
1970 that Elmubrak performed a survey on respiratory diseases in fowl 
but was unable to isolate the virus (Elmubrak, 1970). Elamin and Kheir 
(1985) demonstrated antibodies (Abs) to influenza virus in the sera of 
large animals in Kasala region by using AGPT test.  Manal (2000) was 
able to isolate the virus from outbreaks in Khartoum state and 
demonstrated the presence of Abs in the sera from birds brought to the 
CVRL for diagnosis. Huda and Samar (2006) carried out a study on AI 
in human and chicken sera by using antigens of H5N1 and H7N3. The 
sera were tested by agar gel immunodiffusion test and hemagglutination 
inhibition test, the study was conducted three month before the recent 
outbreak of AI in 2006. They obtained positive results for both human 
and bird's sera. Wegdan and Kheir (2007) isolated the HPAI H5N1 from 
the outbreak in 2006. They isolated the virus from the samples collected 
from six farms in Khartoum and two farms from AlGazeera state. The 
present work was therefore, carried out to investigate the presence of 
antibodies to AI  in chicken and few numbers of humans in contact with 
them by using AGPT and sub typing the positive sera by HI test using 
antigens of H5N1 and H7N3, before and after 2006 outbreak.  
Objectives: 
General objective: 
Serosurvillance on avian influenza in Khartoum state. 
Specific objectives: 
 1-Detect Abs to avian influenza by using agar gel immunodiffusion 
test. 
   2-Subtyping of positive sera by using antigens of H5N1 and H7N3 
by HI test. 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
1. REVIEW OF THE LITERATURE 
1.1Definition: 
    Avian influenza (AI) is a disease of viral etiology that ranges from 
a mild or even asymptomatic infection to an acute, fatal disease of 
chickens, turkeys, guinea fowls, and other avian species, especially 
migratory waterfowl (Alexander, 1982 and Easterday et al., 1997). The 
disease was first defined in 1878 and became known as fowl plague. In 
1981 the term fowl plague was abandoned and the term highly 
pathogenic avian influenza (HPAI) viruses are adopted for viruses 
causing clinical disease with high mortality (Jordan, 1990). The disease 
has an incubation period of 24 hours to 7 days depending on the dose of 
virus and the route of entry (Easterday and Beard, 1984).  Factors such 
as over crowding, poor ventilation, and concurrent infection may 
predispose to the development of severe disease. Clinical signs are more 
apparent in birds, which survive for few days, which include respiratory 
distress, diarrhea, edema in the cranial region, cyanosis, sinusitis and 
lacrimation. Infection of laying birds results in a dramatic drop in egg 
production (Quinn et al., 2004). 
       Lesion is varied according to the virulence. Low virulent viruses 
show lesion mainly in respiratory tract and sinusitis with mucoplurent to 
caseous exudates. Highly pathogenic infection results in edema, 
hyperemia, hemorrhage and degenerative necrotic foci in the visceral 
organs (Jordan, 1990).  
 
 
1.2 History of the disease:         
AI was first defined in 1878 in Italy, Centanni and Savunozz 
described the nature of the organism that cause fowl plague in 
1901(Stubbs, 1965). It was until 1955 that Schafer demonstrated that 
fowl plague virus had ribonucleoprotein (RNP) characteristic of type A 
influenza viruses (Stubbs, 1965). Two antigenic types of A influenza 
viruses were isolated from duck with respiratory disease in 1956, one in 
England and one in Czechoslovakia (Koppel et al., 1956; Roberts, 1964). 
The first avian influenza viruses were isolated in North America in 1963 
from turkeys, after that many viruses were isolated from domestic or 
confined birds in North America, England, Germany, Italy, and 
Yugoslavia (Easterday and Tumova, 1978). In 1981 the term fowl plague 
was abandoned and the term highly pathogenic avian influenza (HPAI) 
viruses was dopted for viruses causing clinical disease involving high 
mortality (Jordon, 1990). In March and April 1997, there were outbreaks 
of H5N1 avian influenza viruses on several poultry farms in the province 
of Hong Kong (CDC, 1997; Shortridge et al., 1998). These viruses were 
highly pathogenic in chicken and resulted in high mortality among 
infected birds (Claas et al., 1998b; Suarez et al., 1998; Subbarao et al., 
1998). 
In the same year zoontic transmission of H5N1 (HPAI) caused 18 
cases of human infection with six fatalities (CDC, 1997; CDC, 1998). 
During the past few years in Italy, there have been several epidemics of 
avian influenza in domestic poultry that were caused by highly 
pathogenic (HP) H5N2 virus in 1997 and by both low-pathogenic (LP) 
and HP H7N1 influenza viruses in 1999 through 2001(Capua et al., 
2000; Capua et al.,  2002; Donatelli et al., 2001). 
 1.3 Characteristics of influenza virus: 
    The influenza A viruses belong to the family Orthomyxoviridae 
(Lamb, 1989). Orthomyxovirus virions are pleomorphic, often spherical 
but predominantly filamentous in fresh isolates, 80 – 120 nm in their 
smallest dimension (Murphy et al, 1999). The virus has an envelope with 
a host-derived lipid bilayer and covered with about 500 projecting 
glycoprotein spikes with hemagglutinating and neuraminidase activities. 
These activities correspond to the two major surface viral glycoprotein's: 
the hemagglutinin (HA) and neuraminidase (NA), present as 
homotrimers and homotetramers respectively. Within the envelope, a 
matrix protein (M1) and a nucleocapsid (NP) protein protect the viral 
RNA (Lamb, 1989). The type designation (A, B, or C) is based upon the 
antigenic features of the M1 and NP proteins. Eight segments of single 
stranded RNA of negative polarity, totaling approximately 14 kilobases, 
encode for at least 10 viral proteins (McGeoch et al., 1976).  
Approximately half of the total genome encodes for the three viral 
polymerase proteins (segments 1, 2 and 3; (Palese et al., 1977). Segment 
5 encodes the NP protein; three-polymerase subunits, the NP and the 
vRNA are associated in virions and infected cells in the form of viral 
ribonucleoprotein particles (vRNPs). Segments 4 and 6 encode for the 
HA and NA genes. The two smallest segments (7 and 8) encode two 
genes each with overlapping reading frames, which are generated by 
splicing of the co-linear mRNA molecules (Lamb and Lai, 1980; Lamb 
and Lai, 1984; Lamb et al., 1981).  In addition to M1, segment 7 encodes 
for the M2 protein, which has ion channel activity and is embedded in 
the viral envelope. Segment 8 encodes for NS1, a nonstructural protein 
that blocks the host’s antiviral response, and NS2 or NEP that 
participates in the assembly of virus particles. 
1.4 Virions properties: 
1.4.1 Biological properties: 
       All strains of influenza viruses are capable of agglutinating the 
erythrocytes from human, guinea pigs and chicken as well as many 
species. The HA together with neuraminidase act as the two major strain 
specific surface antigens and are very important. The hemagglutinin 
functions are to initiate virus attachment to cellular receptors and the 
neuraminidase is responsible for the cleavage of the sialic acid 
containing receptor and elution of the viral particle from host cell 
(Ardans, 1999). To date there is 16 HA subtypes (H1- H16) and 9 NA 
subtypes (N1- N9) of influenza A viruses have been identified (Fouchier 
et al., 2005). There are differences between AI strains isolated from the 
same species in the same locality (Pereira et al., 1967; Lang et al., 
1968a, b). Selmons and Easterday (1972) demonstrated that a virus strain 
highly fatal for turkeys had little effect on pheasant, ducks and pigeons. 
Beard and Easterday (1973) found that a virus isolated from turkeys had 
HA similar to avian influenza avirulent for young chicken. 
1.4.2 Physical properties: 
        The influenza viruses are relatively unstable in the environment.  
Heat, extreme changes of pH, or non-isotonic conditions and dryness can 
readily inactivate the influenza viruses (Lamb, 1989). Influenza viruses 
are inactivated by ultra - violet, irradiation. They are relatively stable at 
pH 7-8 but labile at low pH (Lang et al., 1968a). Franklin and Wecker 
(1959), Laver (1963) reported that infectivity of avian influenza is 
rapidly destroyed by formaldehyde, detergents, oxidizing agents 
(iodine), dilute acid, ether, sodium deoxycholate and ammonium ions. AI 
survived after 15 minutes at 55°C but was destroyed after 5 minutes or 
less at 60°C (Moses et al., 1948). Hemagglutinin and infections capacity 
can usually be maintained for several weeks at 4°C (Easterday and 
Tumova, 1978). The optimum temperature for virus synthesis is 37°C, 
influenza virus retains infectivity in fecal materials for at least 30 days at 
4°C and for 7 days at 20°C (Robert et al., 1978).  
1.4.3 Chemical composition: 
          AI genome consists of several segments (at least 8 segments) of 
single – stranded RNA (Pons, 1975). Choppin and Compans (1975) 
reported that influenza virions consist of 0.8 – 1.1% RNA. The virus also 
contains 70 -75% proteins, 20 -24% lipid and 5 -8% carbohydrate. The 
lipids are located in the viral membrane; most of them are phospholipids 
with smaller amounts of cholesterol and glycolipids. Several 
carbohydrates including ribose (in the RNA), galactose, mannose, 
fructose and glucosamine are present in the virion mainly as 
glycoproteins or glycolipids (Choppin and Compans, 1975). 
 1.4.4 Replication of avian influenza virus: 
            Influenza virus attachment to the susceptible cell is mediated by 
the interaction between the viral hemagglutinin and sialic acid receptors 
present on glycolipids and glycoproteins on the cell surface (Lamb, 
1989). At this stage, the sialidase activity of the neuraminidase prevents 
binding of the HA to sialic acids present in mucopolysaccharadies, 
which would interfere with the virus binding to the adequate cellular 
receptors. The virus is internalized by endocytosis and, upon 
acidification of the endosome, conformational changes on the 
hemagglutinin lead to the fusion between the viral and the endosomal 
membranes (Lamb, 1989). Acidification of the endosomal lumen also 
activates the ion channel activity of the viral membrane protein M2 
(Pinto et al., 1992). Transcription complexes (nucleocapsid with 
associated RNA polymerase) are released into the cytoplasm after fusion 
between the viral envelope and the endosomal membrane, then they are 
transported into the nucleus where transcription and RNA replication 
take place (Murphy et al., 1999). Two different populations of positive 
sense RNAs are synthesized from vRNA templates: messenger RNAs 
(mRNAs) and complementary RNAs (cRNAs). Viral mRNAs are primed 
by 5’ capped (m7GpppNm-containing) fragments derived from newly 
synthesized host-cell RNA polymerase II transcripts (Beaton and Krug, 
1986; Krug et al., 1989; Plotch et al., 1981; Ulmanen et al., 1983). Viral 
mRNAs are polyadenylated by a stuttering mechanism involving the 
viral polymerase and a stretch of uridines, which are located 17-22 
nucleotides before the 5’ end of the vRNAs (Hay et al., 1977; Robertson 
et al., 1981). Synthesis of cRNA is the first step in influenza virus 
replication. Transcription of cRNAs occurs in the absence of primer or 
polyadenylation and they represent full-length copies of vRNAs 
(McGeoch et al., 1976). The second step in viral replication is the 
synthesis of progeny vRNA molecules from cRNAs templates 
(McGeoch et al., 1976). Towards the end of the infection cycle and once 
enough molecules of M1 and NEP have been produced, the newly 
synthesized vRNPs are exported out of the nucleus and assembled into 
full virus particles. The final assembly steps occur at the plasma 
membrane exposing the newly synthesized hemagglutinin, 
neuraminidase proteins, and M2 (Helenius, 1992). Once the final 
assembly events are completed, new virus particles bud from the plasma 
membrane. The activity of the neuraminidase becomes again important 
by disrupting viral aggregates and thus releasing viral particles that can 
start a new cycle of infection. 
1.5 Classification of avian influenza virus: 
Hagan and Bruner (1988) reported that the virus is classified into: 
Family:                                            Orthomyxoviridae 
Genus:                                            Orthomyxovirus 
Type species:                                           Type A                              
  Subtype:                                   (1) Human influenza viruses 
                                                              A/PR8/ 34 
                                                             A1/Cam/ 46 
                                                             A2/Singsore/1/ 57    
                                                  (2) Equine influenza viruses 
                               Equi-1/Praha/ 56 
                                                         Equi-2/Miami/ 63 
                                                  (3) Porcine influenza viruses 
                             A/SW/Lowa/ 31 
                                                        A/SW/Wis/ 61 
                                                        A/SW/Wis/ 68                                                               
                                                  (4) Avian influenza viruses 
                                                    Fowl Plague/27 
                                                       A/Duck/Czech/ 56   
                                                       A/Chick/Scot/ 59 
                                                      A/Turkey/Can/ 63 
                                                     A/Turkey/Ontario/7732/66   
                                                    A/Quail/Italy/ 1117/65 
Type species:         Type B 
Subtypes:                                Human influenza viruses                        
                                                  B/Lee/40 
                    B/Johannesburg/ 59 
                                                 B/Taiwan/ 62                                                   
Type species:                                  Type C 
                                                 C/Taylor/1233/47   
Murphy et al (1999) and Quinn et al (2004) mention that the family 
Orthomyxoviridae contain four genera influenza, A, B, C and 
Thogotovirus 
1.5.1 H5N1 viruses: 
      The bird flu virus, known as A (H5N1), belongs to a group of 
influenza viruses known as Type A, which are the only ones that have 
caused pandemics.   
The apparent lethality of A (H5N1), combined with its inexorable 
spread, are what have made scientists take it seriously. The virus lacks 
just one trait that could turn it into a pandemic: transmissibility, the 
ability to spread easily from person to person. If the virus acquires that 
ability, a worldwide epidemic could erupt. The A (H5N1) strains 
circulating now are quite different from the A (H5N1) strain detected in 
Hong Kong in 1997, which killed 6 of 18 human victims. Over time, A 
(H5N1) seems to have developed the ability to infect more and more 
species of birds, and has found its way into mammals-specifically, cats 
that have eaten infected birds (OIE, 2006a). 
    H5N1 has mutated into a variety of strains with differing 
pathogenic profiles, some pathogenic to one species but not others, some 
pathogenic to multiple species. Through antigenic drift, H5N1 has 
mutated into dozens of highly pathogenic varieties divided into genetic 
clades which are known from specific isolates. But all currently isolated 
belong to genotype Z of AI virus H5N1 which now is the dominant 
genotype (WHO, global influenza programme surveillance net work, 
2005; Kou et al., 2005). Genotype Z is endemic in birds in Southeast 
Asia, has created at least two clades that can infect human, and is 
spreading across the globe in bird population. Mutations are occurring 
within this genotype that is increasing their pathogencity. Birds are also 
able to shed the virus for prolong period of time before their death, 
increasing the transmissibility of the virus (WHO, global influenza 
program Surveillance net work, 2005). Outbreaks of highly pathogenic 
avian influenza (HPAI) H5N1 virus were initially observed in southern 
China in 1996 and 1997 (Claas et al., 1998, Guan et al., 1999 and Xu et 
al., 1999). It caused major poultry outbreaks in Vietnam, Thailand, 
Indonesia and other East Asian countries since early 2004(Lie et al., 
2004; Vieshakual et al., 2004; Tiensin et al., 2005 and WHO, 2005a). 
The virus is now endemic in poultry in these countries and has caused 
repeated zoonotic transmission to humans (Chotpitayasunondh et al., 
2005; Hien et al., 2004; Puthavathana et al., 2005).  
           In Southeast Asia in 2004, the majority of human infections were 
recognized in Vietnam and Thailand (WHO, 2005b; WHO, 2005c). 
Since mid-2005, there has been a resurgence in the number of human 
H5N1 infections with cases recognized in Indonesia and also more 
recently in China and Turkey (WHO, 2005c; Yu et al., 2005). So far, a 
total of 184 people have been confirmed as having H5N1 disease, 103 of 
these cases having a fatal outcome (WHO, 2005c). The persistent 
introduction of H5N1 virus to humans raises the possibility of emerging 
as a human pandemic virus, either as a purely avian virus adapting to 
more efficient human transmission or through reassortment with current 
human influenza strains (Webster et al., 1992; Taubenberger et al., 
2005). Although some cases of human H5N1 infection were of family 
clusters, human-to-human transmission is still very limited (Ungchusak 
et al., 2005). There is still no convincing evidence for sustained chains of 
transmission within human. Thus, infection from affected poultry 
continues to be the major source of the human cases (WHO, 2005b). 
Genetic analyses has shown that most H5N1 influenza viruses from 
poultry and from humans in these countries belong to a single dominant 
genotype Z that was first recognized in poultry from southern China in 
2002 (Guan et al., 2004; Li et al., 2004; Puthavathana et al., 2005; 
WHO, 2005a). However, an additional genotype of H5N1 virus has been 
identified in Vietnam in 2005 and was first isolated from poultry in 
southern China in early 2005 (Chen et al., 2006). Recent findings show 
that long-term endemicity of H5N1 influenza in poultry has resulted in 
the establishment of multiple regional sub lineages, even among viruses 
that belong to the same genotype (Chen et al., 2006; WHO, 2005a). 
Genetic characterization of H5N1 viruses from Southeast Asia and 
southern China identified a number of amino acid residues in the HA 
that appear to be unique to virus clades from different regions, and that 
these changes are concentrated at antigenic and receptor-binding sites 
(WHO, 2005a).    
1.5.2 H7N3 virus: 
H7N3 is a subtype of the influenza A virus. It was first detected in 
turkeys in Britain in 1963, it also appeared in Canada in February 2004 
but in humans (International Committee on Taxonomy of viruses, 2002).  
On February, 2004 avian influenza was detected on a commercial 
chicken breeder farm in British Columbia, Canada. The virus was 
characterized as an H7N3 subtype. Clinical signs on the index farm 
initially were mild drops in egg production and feed consumption and a 
minor increase in mortality. Gross lesions observed included lung lesions 
and inflamed trachea (Spackman, 2005). Spackman et al (2006) reported 
that an H7N3 AI virus was isolated from a Cinnamon Teal (Anas 
Cyanoptera) (A/CinnamonTeal/Bolivia.4537/01) during a survey of wild 
waterfowl in Bolivia in 2001. The NA and M genes had the greatest 
identity with North American wild bird isolates, the NS was most closely 
related to an Equine virus and the remaining genes were most closely 
related to isolates from an outbreak of H7N3 in commercial chickens in 
Chile in 2002. The HA protein cleavage site and results of pathogenesis 
studies in chickens were consistent with a low pathogenicity virus and 
the infective dose was 100,000 times higher for chickens than turkeys. 
In autumn 2001, two influenza viruses belonging to the H7N3 
subtype were isolated for the first time from wild ducks in Italy. Then, in 
October 2002, a new epidemic of LP H7N3 influenza virus started 
spreading among farms in Northern Italy that intensively rear turkeys 
and chickens. The H7N3 virus affected the same region devastated by 
the 1999–2000 H7N1 epidemics (Capua et al., 2002). H7N3 was found 
in the UK in April 2006, it appeared for the first time since 1976. It 
affected the birds and one person who was working in the affected farm 
(Webster et al., 2003). 
One of the poultry workers who worked at Watford Lodge Farm 
in Norfolk, England, has become infected with the H7N3 Bird Flu virus 
strain. He is not in hospital, as H7 does not make humans very ill, but he 
has conjunctivitis. He or she had been in close physical contact with 
infected birds. The worker did not want to be named. Antiviral Tamiflu 
was administered to poultry workers on the farm as a precautionary 
measure. H7N3 infected birds had been found in the Norfolk farm a few 
days ago. Laboratory tests confirmed the presence of H7N3.The H7N3 
strain was last found in the UK in 1979 (Medical News Today, 2006). 
1.6 Mutations of avian influenza virus: 
        One of the principal biological properties of influenza viruses is 
their antigenic variability which takes two forms, antigenic drift and 
antigenic shift. The antigenic drift is a consequence of the low fidelity of 
RNA-dependent RNA polymerase of influenza A viruses combined with 
selection pressure exercised by neutralizing Abs directed toward the five 
antigenic sites ( A, B, C, D and E ) exhibited on the HA surface ( Fitch et 
al., 1997).This may lead to gradual accumulation in these sites of a series 
of point mutation which enables influenza A viruses to invade the host 
immune system and cause infection despite pre-existing antibodies 
(Wilson and Cox, 1990; Smith, 2003).  
Each new antigenic drift variant of influenza A capable of causing 
a reinfection in a previously exposed host appears to have at least four 
amino acid substitutions located in two or more antigenic sites of the HA 
protein (Cox and Bender, 1995). The antigenic shift  which takes place 
when two different viruses from two different host species co-infected a 
single host, facilitates the exchange of genetic information 
(reassortment) between influenza A viruses and allows the virus to 
undergo unpredictable evolutionary leaps (Zambon, 2001). For example 
in April 1983, H5N2 influenza virus was introduced from wild birds into 
chicken flocks in Pennsylvania producing a mortality of less than 10%. 
However in October  the accumulation of about seven point mutations in 
the hemagglutinin gene of this virus resulted in an increase in mortality 
to over 80% and a coincident increase in viral transmissibility- all 
contributed to an epidemic that cost the regional poultry industry more 
than $ 60 million (Murphy et al., 1999). In August 1997, an H5N1 AI 
caused outbreak in chicken flocks in Hong Kong and the virus was 
transmitted to humans and caused death; that was the first time for AI to 
cause host species jumping without genetic reassortment (Murphy et al., 
1999).  
 
 1.7 Epizootiology: 
The epizootiology of influenza virus infection among avian 
species is poorly understood. The virus is introduced into susceptible 
flocks periodically by interspecies transmission i.e. between chicken and 
turkeys and from wild birds especially wild ducks.(Murphy et al., 1999). 
Aquatic birds are the natural reservoir of influenza A viruses (Hinshaw 
et al., 1980a) which replicate in the gastrointestinal tract of waterfowl 
and are transmitted by the fecal–oral route (Hinshaw et al., 1980b). 
Influenza A viruses in other hosts, including humans, have ancestral 
links to waterfowl influenza viruses (reviewed in Webster et al, 1992; 
Webby and Webster, 2001). However, influenza viruses from waterfowl 
replicate poorly in humans (Beare and Webster, 1991) and other 
primates (Murphy et al., 1982a; Murphy et al., 1982b  ), and human 
viruses replicate poorly in ducks (Hinshaw et al., 1983). Therefore, 
waterfowl viruses must undergo change before they can cross the species 
barrier. Because of the segmented nature of their genome, influenza 
viruses can reassort. Human influenza viruses are thought to be able to 
acquire genes from waterfowl influenza viruses through reassortment or 
adaptation in a mammalian intermediate host. Pigs, which are susceptible 
to infection with both avian and human influenza viruses (Kida et al., 
1994), are postulated to be an important intermediate host that acts as a 
“mixing vessel” in which such reassortment takes place (Scholtissek, 
1990). In nature, a limited number of avian and human influenza viruses 
have established stable lineages in pigs. Occasional transmission of 
influenza viruses from pigs to humans, with resulting respiratory disease, 
has also been documented (reviewed by Brown, 2000). A new picture 
emerged in 1997, when H5N1 viruses circulating in poultry in Hong 
Kong were transmitted directly to humans. Six of 18 people known to be 
infected died (reviewed by Shortridge, 1999). In 1999, viruses of the 
H9N2 subtype, which are endemic in poultry species in Asia, were 
transmitted to humans and pigs; they caused mild respiratory disease in 
some humans but were not lethal (Peiris et al., 1999; Lin et al., 2000; 
Guo et al., 1999). These incidents raised the possibility that land-based 
poultry species are a potential source of influenza viruses that can cross 
to humans (Shortridge et al., 1998; Webby and Webster, 2001).  
Recent observations suggest that the potential role of quail 
(Coturnix contouring) as intermediate hosts in the interspecies 
transmission of influenza viruses has been underestimated. The first 
reported cases of influenza A respiratory disease in quail occurred in 
Italy during 1966–1968. Influenza viruses of several subtypes (H5N2, 
H7N2, H7N3, H9N2, and H10N8) have since been isolated from quail in 
North America, Europe, and Asia in the course of sporadic surveillance 
(Guan et al., 1999; Guo et al., 2000; Saito et al., 1993; Suarez et al., 
1999). Stubbs (1965) reported that while influenza virus can spread very 
rapidly among various species it may be that one species is infected in a 
farm that contains more than one species; this was supported by walker 
and Bannister (1953) who isolated the virus from ducks and not from 
chickens, turkeys and geese which were placed in the same farm.  
1.8 Transmission:   
Wild aquatic birds are the natural reservoir of influenza type A 
viruses and play an important role in the ecology and propagation of 
these viruses (Webster et al., 1992; Hinshaw et al., 1980). Campitelli et 
al (2004) described the antigenic and genetic characterization of the 
surface proteins of H7N3 virus isolated from wild ducks in Italy in 2001 
in comparison to H7N3 strain circulated in Italian turkeys in 2002-2003. 
The wild and domestic avian strains appeared strictly related at both 
phenotypic and genetic level: homology percentages in seven of their 
genes were comprised between 99.8% (for PB2) and 99.1% (for M), and 
their NA genes differed mainly because of a 23- amino acid deletion in 
the NA stalk. Outside this region of the molecule, the NAs of the two 
virus groups showed 99% similarity. This finding indicates that turkey 
H7N3 viruses were derived from avian influenza strains circulating in 
wild waterfowl 1 year earlier. Transmission between birds occurs 
directly or indirectly through fecally contaminated aerosols, water, feed, 
and other materials (Jong and Hien, 2006). AI may be transmitted on 
such objects as shoes, clothing and crats that come in contact with 
infected birds or premises (Ardans, 1999). 
Ardans (1999) also reported influenza that can persist in some 
birds for several months after infection. Infected ducks can shed virus for 
prolonged periods without showing clinical signs or producing 
detectable antibody response.   
1.9 Clinical signs: 
      Avian influenza in poultry may cause asymptomatic infection or 
mild illness to severe systemic infection with high mortality (Alexander, 
2000). All the ages of chicken are susceptible but the disease is usually 
seen in layers (Johnson and Maxfield, 1976). The severity of infection 
depending on factors such as overcrowding, poor ventilation and 
concurrent infections. The incubation period varied up to seven days 
(Quinn et al., 2004). HPAI virus infections, which are caused by some 
viruses of the H5 and H7 subtypes, usually result in multiorgan systemic 
disease, with high rates of morbidity and mortality. LPAI viruses are 
more commonly isolated from domestic poultry and may be associated 
with mild respiratory disease and reduction in eggs production 
(Alexander, 2000; Easterday et al., 1997; Swayne and Suarez, 2000). In 
particular, viruses of the H5 and H7 subtypes can cause highly 
pathogenic avian influenza, a systemic disease of high morbidity and 
mortality in domestic poultry (Suarez, 2000). If birds survive for more 
than 48 hours there is a cessation of egg laying, respiratory distress, 
lacrimation, sinusitis, diarrhea, edema of the head, face and neck and 
cyanosis of unfeathered skin particularly the comb and wattles. Less 
virulent viruses may also cause considerable losses particularly in 
turkeys, because of anorexia, decreased egg production, respiratory 
disease and sinusitis (Murphy et al., 1999). 
1.10 Lesions: 
            Histological lesions may not be apparent in birds that died soon 
after the onset of the infection other than severe congestion of the 
musculature and dehydration. However, in birds that survive the acute 
form of the disease, significant gross lesions are observed, although they 
may resemble those observed with velogenic viscerotropic Newcastle 
disease (NDV), and thus, they cannot be used for differential diagnosis 
of HPAI. During post-mortem examination, fluid and mucous exudates 
from the nares, oral cavity, the trachea, and subcutaneous edema of the 
head and neck may be observed. The conjunctivae are severely 
congested, often presenting petechia. Pinpoint petechiae are frequently 
observed on the inside of the keel, the abdominal fat, serials surfaces, 
and peritoneum. Kidney function is usually severely compromised, with 
tubules that are plugged with white deposits of urate. In layers, the ovary 
may be hemorrhagic or degenerated with darkened areas of necrosis. In 
layers that survive longer than a week, the ova are ruptured and the yolk 
fills the peritoneal cavity causing severe airsacculitis and peritonitis. 
Hemorrhages may be present on the mucosal surface of the 
proventriculus and underneath the gizzard. The intestinal mucosa may 
have hemorrhagic areas, especially in the cecal tonsils and other 
lymphoid foci (Swayne and Halvorson, 2003). 
1.11 Pathogenicity: 
          The pathogencity of avian influenza depending on the strain of 
virus, age, and species infected concurrent infection and husbandry 
(Ardans, 1999). The pathogenicity of the avian viruses, including those 
that caused the human 1997 outbreak, relates primarily to properties of 
the hemagglutinin glycoprotein (HA). Cleavage of the HA precursor 
molecule HA0 is required to activate virus infectivity, and the 
distribution of activating proteases in the host is one of the determinants 
of tropism and, as such, pathogenicity. The HAs of mammalian and 
nonpathogenic avian viruses are cleaved extracellularly, which limits 
their spread in hosts to tissues where the appropriate proteases are 
encountered. On the other hand, the HAs of pathogenic viruses are 
cleaved intracellularly by ubiquitously occurring proteases and therefore 
have the capacity to infect various cell types and cause systemic 
infections (Steinhauer, 1999). The spread of influenza virus in tissue 
depends on the type of proteases present in a given tissue and the 
structure of the viral hemagglutinin molecule.  
Bosch et al (1981) also reported that there is two key structural 
feature that determine the HA cleavability, the amino acid sequence at 
the cleavage site and glycosylation near the cleavage site. The 
production of infectious virions requires cleavage of viral hemagglutinin 
(Quinn et al., 2004). Influenza virus replicate in the respiratory and 
intestinal tracts of infected birds. In infection with virulent strain there is 
aviremia, multifocal lymphoid and visceral necrosis leading to 
pancreatitis, myocarditis, myositis and encephalitis (Jordan, 1990). Of 
the viral particle from host cell, there are nine recognized NA subtypes 
(Ardans, 1999). There are differences between strains isolated from the 
same species in the same locality (Pereira et al., 1967; Lang et al., 
1968a, b). Selmons and Easterday (1972) demonstrated that a virus strain 
highly fatal for turkeys had little effect on pheasant, ducks and pigeons. 
Beard and Easterday (1973) found that a virus isolated from turkeys had 
HA similar to the avirulent influenza virus isolated from young chicken. 
1.12 Diagnosis: 
         The diagnosis of AI virus is by isolation and characterization of 
the virus. This is because infection in birds can give rise to wide variety 
of clinical signs that may vary according to the host, strain of virus, the 
host immune status, presence of any secondary organisms and 
environmental conditions. Samples from dead birds include: intestinal 
content or cloacal swabs, oropharyngeal swabs and tissues (trachea, 
lungs, air sacs, intestine, spleen, kidney, liver, heart and brain). Samples 
from life birds include: tracheal swabs and cloacal swabs. The samples 
should be placed in isotonic phosphate buffer saline (PBS), pH 7.0 – 7.4 
containing antibiotics. When immediate processing is impracticable, 
samples may be stored at 4°C for up to 4 days. For prolonged storage, 
diagnostic samples and isolates should be kept at -80°C (OIE, 2004). 
 
 
1.12.1 Isolation of the viruses: 
1.12.1.1 Embryonated hen's eggs:           
Embryonated hens eggs is the preferred method of growing AI 
viruses, the supernatant fluids of faces or tissue suspensions obtained 
through clarification by centrifugation at 1000g are inoculated into the 
allantoic sac of at least five embryonated specific pathogen free (SPF) or 
specific antibody negative (SAN) fowl eggs of 9 – 11 day incubation. 
Eggs containing dead embryos at the end of incubation periods should be 
chilled at 4ºC and then the allantoic fluid harvested and tested for 
hemagglutination (HA) activity. Detection of HA activity indicates a 
high probability of the presence of an influenza A virus or of an avian 
paramyxovirus (OIE, 2004). 
1.12.1.2 Cell culture: 
         The virus is generally isolated in primary monkey kidney cell 
culture or the Madin- Darby canine kidney cell line. Non – specific 
cytopathologic effects are often difficult to distinguish but may be noted 
within as few as 2 – 4 days (Patrick et al., 2005). 
1.12.2 Serology: 
1.12.2.1 Agar gel immunodiffusion (AGID): 
              AGID is a group-specific test for antibody; it is relatively 
useful on a flock basis for serology for LPAI but of limited use for HPAI 
strains where mortality is high. 
It is of little use to detect virus infection in water fowl as the 
precipitating antibody response to group antigen is generally poor (FAO, 
2004). All influenza A viruses have antigenically similar nucleocapsid 
and antigenically similar matrix antigens. This fact enables the presence 
or absence of antibodies to any influenza A virus to be detected by 
AGID tests. Concentrated virus preparations, as described above, contain 
both matrix and nucleocapsid antigens; the matrix antigen diffuses more 
rapidly than nucleocapsid antigen. AGID tests have been widely and 
routinely used to detect specific antibodies in chicken and turkey flocks 
as an indication of infection. These have generally employed 
nucleocapsid-enriched preparations made from the chorioallantoic 
membranes of embryonated fowl eggs (Beard, 1970) that have been  
infected at 10 days of age homogenized, freeze-thawed three times, and 
centrifuged at 1000 g . The supernatant fluids are inactivated by the 
addition of 0.1% formalin or 1%  betapropiolactone, re-centrifuged and 
used as antigen.  
Not all avian species may produce precipitating antibodies 
following infection with influenza viruses. Tests are usually carried out 
using gels of 1% (w/v) agrose or purified agar and 8% (w/v) NaCl in 
0.1M phosphate buffer, pH 7.2 poured to thickness of 2-3 mm in Petri 
dishes or on microscope slides. Using a template and cutter, wells of 
approximately 5mm in diameter, and 2-3 mm apart, are cut in the agar. A 
pattern of wells must place each suspect serum adjacent to known 
positive serum and antigen. This well makes a continuous line of identity 
between the known positive, the suspected serum and the nucleocapsid 
antigen. Approximately 50мl of each reagent should be added to each 
well. Precipitin lines can be detected after approximately 24-48 hours, 
but this may be dependent on the concentration of the antibody and the 
antigen. These lines are best observed against a dark background that is 
illuminated from behind. A specific, positive result is recorded when the 
precipitin line between the known positive control wells is continuous 
with the line between the antigen and the test well. Crossed lines are 
interpreted to be due to the test serum lacking identity with the 
antibodies in the positive control well (OIE, 2004). 
1.12.2.2 Hemagglutination (HA) and Hemagglutination inhibition 
test (HI): 
 1.12.2.2.1 Hemagglutination (HA) test:  
      The hemagglutinin (HA) protein agglutinates erythrocytes, hence the 
derivation of its name. The traditional method for identifying influenza 
field isolates takes advantage of this property. HA is done in microtiter 
plate and the hemagglutination can be determined by tilting the plates 
and noting the presence or absence of tear-shaped streaming of RBC. 
The highest dilution of virus that causes complete hemagglutination is 
considered the HA titration end point. An HA unit is defined as the 
amount of virus needed to agglutinate an equal volume of a standardized 
red blood cell suspension (WHO, 2002).   
1.12.2.2.2Hemagglutination inhibition test (HI): 
      Specific attachment of antibody to the antigen sites on the HA 
molecule interferes with the binding between the viral HA and receptors 
on the erythrocytes. This effect inhibits hemagglutination and  is the 
basis for the hemagglutination inhibition (HI) test (WHO, 2005). HI test 
is the subtype- specific test recommended. It is sensitive and specific 
when epidemiologically appropriate antigen is used. It can be used for 
monitoring the response to vaccination and where birds survive infection 
(e.g. with LPAI or HPAI in ducks) to monitor circulation of virus (FAO, 
2004).HI test is performed in microtiter plates, in general, a standardized 
quantity of HA antigen is mixed with serially diluted antiserum and red 
blood cells are added to determine specific binding of antibody to the 
HA molecule. The HI titer is the reciprocal of the last dilution of 
antiserum that completely inhibits hemagglutination. The HI test is 
extremely reliable, provided reference antiserums are available to all 
subtypes. The disadvantages of the test are the need to remove 
nonspecific inhibitors which naturally occur in sera, standardize antigen 
each time when the test is performed and the need for specialized 
expertise in reading the results of the test. However HI assay remain the 
test of choice for WHO global influenza surveillance (WHO, 2002). 
1.12.2.3 ELISA: 
Competitive ELISA can be used to detect the antibodies of avian 
influenza viruses. There is sensitive and specific ELISA that 
demonstrates nucleoprotein of type A influenza virus using a monoclonal 
antibody against type A influenza nucleoprotein   (Shafer et al., 1998; 
Slemons and Brugh,1998; Swayne et al., 1998). It is available as a 
commercial kit. 
1.12.2.4 Immunofluorescence: 
Immunofluorescence techniques have been used for rapid 
diagnosis of influenza in human beings (Liu, 196; Hers, 1962) but there 
have been no reports of the use of these techniques for the diagnosis of 
influenza virus infections in avian species (Becker, 1967). 
Immunofluorescence has also been a useful serologic method for the 
detection of very low levels of antibody, compared to complement 
fixation test (CF) and IDD tests. Immunofluorescence test was more 
sensitive and could be used as quantitative method for the detection of 
antibody to RNP and surface antigens (Stumpa et al., 1975). 
1.12.2.5 Neuraminidase inhibition (NI) test: 
The NI is used to identify the AI neuraminidase type of isolates 
and to characterize the antibody in infected birds (Capua et al., 2003). It 
is essentially a biochemical assay inhibited by antibody. The test use 
beta- propiolactone inactivated antigen. The result is a visible colour 
change that can be observed by eye. The method has been conducted in a 
96-well microtiter plate format (FAO, 2004). 
1.12.2.6 Complement fixation test: 
It is used to detect the NP antigen, also to detect the whole virion 
(Henry, 1988). 
1.12.3 Molecular techniques: 
 Molecular techniques have been used in the diagnosis of AI for 
some time. Recently there have been developments in their application 
for detection and characterization of AI virus directly from clinical 
specimens from infected birds.  
1.12.3.1 Reverse transcriptase PCR (RT- PCR): 
RT PCR methods allow for sensitive and specific detection of 
viral nucleic acids and have shown to increase the diagnostic sensitivity 
for many pathogens when compared to culture or antigen detection 
methods. During the H5N1outbreaks in Hong Kong and Southeast Asia, 
RT PCR methods seem to be the diagnostic methods of choice 
(Chotpitayasunondh et al., 2005; Tran et al., 2004; Yuen et al., 1998). 
Especially when using real-time PCR technology, a reliable subtype-
specific diagnostic result can be generated within a few hours after 
specimen collection. A disadvantage of RT PCR method is the proneness 
for contamination and the consequent risk of false-positive results, whish 
should be minimized by proper precautions, including physical 
separation of laboratories for PCR preparation and amplification. In 
addition, the inclusion of an internal control in RT PCR assays is highly 
desirable to monitor for false-negative results due to inefficient nucleic 
acid extraction, cDNA Synthesis, or amplification (Jong and Hien, 
2006). RT PCR techniques on clinical specimens results in rapid 
detection and subtype (at least of H5 and H7) identification (Munch et 
al., 2001; Starick et al., 2000). 
        Results obtained by Koch (2003) indicated that care should be 
taken in clinical specimens used; while tracheal samples from infected 
birds showed high sensitivity and specificity relative to virus isolation, 
the feacal samples lack the sensitivity. This technique was used with 
success during the 2003 highly pathogenic AI outbreaks in the 
Netherland. Modification on the use of RT PCR has been applied to 
reduce the time for both identification of virus subtype and sequencing. 
For example Spackman et al (2002) used a real time single-step RT PCR 
primer/fluorogenic hydrolysis probe system to allow detection of AI 
viruses and determination of subtype H5 or H7. The authors concluded 
that the test performed well relative to virus isolation and offered a 
cheaper and much more rapid alternative with diagnosis on clinical 
samples in less than three hours.   
1.13 Controls of avian influenza:  
The traditional method of controlling and eradicating the highly 
pathogenic avian influenza are the quarantine, restricted movement, and 
culling of infected and adjacent flocks (Lee et al., 2005) other strategies, 
including improved biosecurity and vaccination. 
 
1.13.1 Vaccination: 
         Experimental work have shown that vaccination protects against 
clinical signs and mortality, reduce virus shedding and increases 
resistance to infection, protects from diverse field viruses within the 
same hemagglutinin subtype, also protects from low and high challenge 
virus (Capua et al., 2004; Swayne, 2003). Conventional vaccines are 
used against NAI or LPAI and prepared from infective allantoic fluid 
inactivated by beta- propiolactone or formalin and emulsified with 
mineral oil (Bankowski, 1985). Since 1970 in the USA there are some 
uses of inactivated vaccines produced under special license on 
commercial basis (Halvorson, 1998; Mccapes and Bankowski, 1985; 
Price, 1982). Inactivated vaccines are used world wide to protect against 
different outbreaks of LPAI for examples: Vaccination against H9N2 
infection used in Pakistan (Naeem et al, 1999) and Iran (Swayne, 2005) 
and in turkeys used against H7N3 in 1959 (Halvorson et al, 1998). 
Vaccination against HPAI subtype was used in Mexico following 
outbreaks in 1994 – 1995 and against H7N3 subtype in Pakistan 
following outbreaks in 1995 (Garcia et al., 1998; Lee et al., 2004; 
Naeem, 1998). 
      Recombinant vaccines for AI are produced by inserting the gene 
coding for the influenza virus hemagglutinin into a live virus vector and 
using this recombinant virus to immunize poultry against AI. The use of 
recombinant vaccines is restricted to countries in which they are licensed 
and are legally available. The recombinant fowlpox-AI-H5 vaccine is 
licensed in El Salvador, Guatemala, Mexico and USA (Slemons and 
Brugh, 1998). Other novel vaccines are a baculovirus-expression system 
that was used to produce recombinant H5 and H7 antigens for 
incorporation into vaccines (Wilkinson, 1998) DNA encoding H5 
hemagglutinin was evaluated as a potential vaccine in poultry (Kodihalli 
and Webster, 1998). Reverse genetics was used to create an H5N3 
vaccine for poultry (Liu et al., 2003).  And appears to offer a means of 
preparing inexpensive, efficacious vaccines to highly pathogenic H5N1 
influenza viruses.  
  The N3 neuraminidase was used to allow distinction between 
infected and vaccinated animals (Capua et al., 2003). A dose of HA 
protein as small as 1.2 micrograms protected chickens from lethal H5N1 
challenge and markedly reduced virus  shedding by infected birds. 
Nevertheless, a small number of birds shed small amounts (depending on 
the vaccine dose) of H5N1 influenza virus (Liu et al., 2003). 
1.14 Treatment: 
        Two classes of antiviral drugs are available: 
 1-Amantadine and rimantadine which have antiviral activity against 
influenza viruses by inhibition of the ion channel activity of the M2 
membrane protein. 
2- Oseltamivir and zanamivir which are inhibitors of the neuraminidase. 
 The therapeutic efficacy of amantadine in human influenza is 
unclear due to a paucity of reliable clinical studies, but reductions of 
fever or illness by 1 day have been observed in adults and children 
(Nicholson et al., 2003). Major disadvantages of amantadine include 
neurotoxicity and a rapid development of drug resistance during 
treatment. Resistance is conferred by single nucleotide changes resulting 
in amino acid substitution at positions 26, 27, 30, 31, or 34 of the M2 
protein. Rimantadine causes less neurological side effects but is not 
available in most parts of the world. Although several H5N1- infected 
patients have been treated with amantadine during the 1997 H5N1 
outbreak in Hong Kong (Yuen et al., 1998) the genotype Z H5N1 viruses 
isolated from poultry and human in Thailand and Vietnam in 2004 
invariably showed an amantadine- resistance conferring amino acid 
substitution at position 31 of the M2 protein which indicating that 
amantadine treatment is not an option during the ongoing outbreak in 
southeast Asia (Li et al., 2004; Puthavathana et al.,  2005). Both 
oseltamivir and zanamivir have proven efficacy in the treatment of 
human influenza when started early during the course of illness, and are 
particularly effective as seasonal or post exposure prophylaxis 
(Nicholoson et al., 2003). Zanamivir has poor oral availability and is 
therefore administered by inhalation, which has limited use in the elderly 
and may induce bronchospasm. Oseltamivir can be given orally. The 
development of drug resistance during treatment has been reported for 
both drugs and is associated with mutation in the active site of 
neuraminidase or in the hemagglutinin. The latter mutations decrease the 
affinity of HA for the cellular receptor, thereby obviating the need for 
neuraminidase to escape the cells. Data on the efficacy of the 
neuraminidase inhibitors in AI virus are scarce. The H5N1 strains 
implicated in the 1997 Hong Kong outbreak were susceptible in vitro to 
oseltamivir and zanamivir (Govorkova et al., 2001; Leneva et al., 2000). 
1.15 AI virus infections in Sudan: 
           Avian influenza is a serious disease of poultry and had direct 
effect in economic and puplic health. The first description of the disease 
in Sudan was a report in 1925(Annual report of the Sudan veterinary 
service). El Mubarak (1970) implied a survey on respiratory diseases  in 
fowl but was unable to isolate the virus. Elamine and Kheir (1985) 
detected Abs to influenza virus in large animals in Kasala region in 
eastern Sudan by using AGPT and the result of that study showed 
positive reaction to influenza type A in two (4.7%) of camels sera, Four 
(5.4%) of goat sera, six (7.2%) of sheep sera, two (2.9%) of cattle sera 
and no Abs were detected in donkey sera. 
          Manal (2000) was able to isolate the avian influenza virus from   
outbreaks in   poultry farm in Khartoum state. She collected 97 samples 
that contain 33 tracheal swabs, 22 clocal swabs and 42 tissues (lung, 
trachea, liver, spleen and heart). The results showed 31 positive samples 
from 97 samples, with one isolate (4.5%) from 22 clocal swabs, 18 
isolates (54.5%) from 33 tracheal swabs and 12 isolates (28.6%) from 42 
tissues samples (lung, trachea, liver, and heart. She subtyped the isolates 
using H1N1 and H3N2 antiserum by HI test. Only two isolated were 
inhibited by AI antiserum H3N2. 
  Huda (2006) conducted a study to standardize the agar gel 
immunodiffusion test (AGID) and applied the standardized method for 
two hundred sera collected from human and chicken. She found that the 
most AGID standard method that can be used for diagnosis of AI by 
using purified agar in normal saline with addition of sodium 
deoxycholate. The mean sero-positivity of antibodies to AI virus using 
the standard AGID procedure was 24% out of 100 human sera and 32% 
out of 100 chicken sera. Samar (2006) carried out a study to standardize 
hemagglutination and hemagglutination inhibition tests for AI viruses 
and applicated the standard method for detection of antibodies in 100 
sera collected randomly from chickens and 100 sera from humans by 
using HI test against H7 and H5 antigens. The results reveled that 21 
samples were positives out of 100 sera collected from chicken with 
antibodies against H7 antigens and the titer ranged between 24 and 28. 
The same sera were tested against H5 antigens, the result showed two 
positive samples from 100 samples and the titer ranged between 24 and 
27titers. Another 100 human sera were tested against H7, 15 serum 
samples were positive and the titer ranged between 22 and 27. When sera 
tested against H5 the result is one positive from 100 serum samples and 
the titer was 25. Since the start of the current reports of avian influenza in 
many countries in Asia, Europe and the Middle East, Sudan has 
implemented a harmonized action plan involving all stakeholders 
(Veterinary Authorities, public health authorities and poultry producers). 
The action plan is aimed at raising the capacities and capabilities to 
prevent the introduction of avian influenza into the country and to 
efficiently respond to the disease if introduced. According to the report 
of OIE (2006b) AI H5N1 was reported in Sudan in 19 April 2006, firstly 
in two states, Khartoum and Gezira states. Khartoum and Gezira States 
are the most highly populated States in Sudan. Both States are situated at 
the centre of the country. The disease caused 27000 deaths in Khartoum 
North, 35000 in Khartoum state and 14000 deaths in Gezira state. 
Wegdan and Kheir (2007) isolated a HPAI H5N1 from the outbreak in 
2006. They isolated the virus from samples collected from six farms in 
Khartoum and two farms from AlGazeera state. The samples consisted 
of Organs (trachea, lung, intestine and spleen) and tracheal and clocal 
swabs. The samples were tested by rapid immunochromatographic assay 
and then subtyped by isolation in embryonated eggs.   
 
 
CHAPTER TWO 
2. MATERIAL AND METHODS 
2.1 Preparation and sterilization of glassware:  
  Pipettes, Peteridishes, Pestles and mortars, Test tubes, Forceps, 
scalpels; scissors, were sterilized in the hot oven at 160°C for tow hours. 
Tips, appendrf tubes, sand, bottles with rubber caps, buffer solutions 
were autoclaved at 121°C for 15 minutes. Microtiter plates were shaken 
in solution of 1% NaoH until the red cells were loosened and removed, 
and then they were soaked in the same solution over night. The 
following day, they were rinsed in tap water and soaked in hydrochloric 
acid (HCL) solution for tow hours. Then they were rinsed in four 
changes of deionized distilled water and left to dry at room temperature. 
2. 2 Avian influenza viruses: 
 Reference strains of H7N3/Mallad/Neth/12/00 and 
H5N1/Mallad/Neth/12/00 was donated by WHO Reference Laboratory 
in U of K. 
2. 3 Chicks:   
White Bovan chicks were obtained from Coral company 
Khartoum at one day old and then housed in cages for 8 weeks then used 
in preparation of hyper immune serum.  
 2. 4 Embryonated hen's eggs: 
One day old fertile eggs were obtained from a flock of white 
Bovan chickens at Department of Microbiology, Faculty of Veterinary 
Medicine, U of K. The eggs were incubated at 37 °C in an egg incubator 
and were turned daily for 9-11 days. 
2.5 Propagation of AI viruses: 
2. 5. 1 Embryonated Eggs inoculation:   
Nine to eleven days-old embryonated eggs were candled before 
inoculation in a dark room to check for the viability. The eggs were 
cleaned by sterile distilled water and then disinfected by swabbing with 
70% alcohol. 
2. 5.1.1 Inoculation into the allantoic cavity:    
The eggs were candled to choose the area for inoculation, then a 
line was made around the air sac and a cross was made 2-4 mm over the 
air sac with a pencil. A pore was made on the cross then 0.2ml of 
inoculum was inoculated into allantoic cavity by sterile disposable 1ml 
syringes. The pore was sealed with wax and the eggs were incubated at 
37°C for 5days. Eggs were candled daily to check for embryo death. 
Embryo died during 24 hours of inoculation was discarded and those 
died after that were transferred to refrigerator at 4 C for at least 2 hours. 
2. 5.1.1 Harvesting of the allantoic fluids:    
Eggs were disinfected by 70% alcohol and the shell over the air 
sac was removed using sterile forceps .The chorioallantoic membrane 
(CAM) was ruptured and the amnioallantoic fluids were collected by 
sterile syringe into sterile bottles. The amnioallantoic fluid was 
centrifuged at 1000 rpm for 5 minutes and then kept at -20oC till used. 
2. 6 Preparation of the hyper immune serum (HIS) in chicks: 
Sixteen one day old chicks were divided into two groups of two 
chicks in each group .The two groups were immunized by intravenous 
route with influenza antigens. The first group was immunized with 
H5N1 influenza antigen and the second group immunized with H7N3 
influenza antigen. The chicks were inoculated three times at weekly 
intervals. In each injection each chick received 0.5 ml of antigen 
intravenously. The blood was collected after the first and the second 
dose from the wing vein and the blood left to clot overnight, then the 
sera were carefully collected from the clot, centrifuged at 1000rpm for 5 
minutes and the serum tested by agar gel immunodiffusion test and by 
hemagglutination inhibition (HI) test to determine the titer of Abs. After 
the third injection the chicks were left for two weeks and the blood was 
collected by heart puncture in sterile tubes then the tubes put at slanting 
position for one hour and kept in the refrigerator overnight, the serum 
was separated from the clot in sterile tubes, centrifuged at 1000rpm for 5 
minutes and stored in sterile containers at –20oC till used. 
2. 7   Collection of Blood samples for the serological survey:                                         
              One hundreds and ninety blood samples were collected from   
apparently healthy chickens from different farms in Khartoum state 
during the period March and April, 2006. The blood samples consisted 
of 73 samples from Broiler chicken and 117 samples from Layer 
chicken. Ten blood samples were collected from laborers who work in 
these farms. Blood was collected from the wing vein of chicken using 
1ml syringes and left over night at room temperature to clot. Serum was 
then separated from the clot, centrifuged at 1000rpm for 5 minutes. 
Separated sera were kept in labeled Eppendorf tubes and stored at – 
20°C till used. 
Table 1: Location, type of chicken, age, and number of samples 
 
Location Type of 
chicken 
Age of 
chicken 
Number of  
serum 
samples 
Bahry(FarmS1) Broiler 
chicken 3 weeks 24 Samples 
Bahry(FarmS2) _ 
4 weeks 21 Samples 
Omdurman 
 
_ 
6 weeks 28 Samples 
Bahry(Farm 
A1) 
Layer 
chicken 24 weeks 32 Samples 
 Bahry(Farm 
A2) 
_ 14week 23 samples 
Khartoum(Farm
E) 
_ 28 weeks 22 Samples 
Khartoum(Farm
K1) 
_ 40 weeks 20 Samples 
Khartoum(Farm
K2) 
_ 92 weeks 20 Samples 
S: Shambat 
A: El halfaia. 
E: El Remeyla. 
K: El Klakla 
     
 
 
 
 
 2. 8 Serological Methods: 
2. 8. 1 Agar gel precipitation test: 
This was done according to modified method of OIE (2004) 
2. 8. 1. 1 Preparation of H5N1 antigen for AGID test: 
Antigen of avian influenza H5N1 was prepared on the 
chorioallantoic membrane (CAM) for use in the AGID test. 
2.8. 1. 1. 1 Inoculation on the chorioallantoic membrane (CAM):                                 
  A hole was made through the shell of the air sac by the pointed 
punch and another hole on the top of the egg just to penetrate the shell 
and shell membrane. The dropping of the membrane was verified in a 
dark room by candling, and then a rubber bulb was placed over the hole 
in the air sac to slowly aspirate air from the sac by releasing pressure on 
the deflated bulb. The suction caused false air sac in the area of the 
second hole. To deliver the inoculums on the chorioallantoic membrane 
(CAM), the tip of one ml needle was inserted just within the shell and 
0.2ml was inoculated into embryonated eggs. Then the hole was sealed 
with wax and the eggs were incubated at 37C and examined daily for 5 
days. 
2. 8. 1. 1. 2 Harvesting of the Chorioallantoic membrane (CAM): 
After removal of the shell over the air sac the egg contents were 
discarded and the CAM was removed from the shell and placed in a Petri 
dish, washed by sterile normal saline to remove the yolk. The CAM was 
examined for the presence of hemorrhage and/or thickness which 
indicated the presence of the virus. The CAM was ground in a mortar 
with the aid of normal saline and sterile sand using a pestle. The ground 
CAM was frozen and thawed three time then centrifuged at 1000 rpm for 
5 minutes .The supernatant was collected carefully and tested for the 
presence of the hemagglutination activity, then the antigen was kept at -
20 C until used in the agar gel precipitation test. 
2. 8. 1. 2 Preparation of agar gel: 
A weight of 1.6 grams of purified agar and 8 grams of NaCL were 
dissolved in 100 ml distilled water and 0.5 ml of phenol was added to the 
solution as preservative. The solution was heated in a microwave for 2 
minutes, 5 ml of the agar was distributed in Petri dish and then placed on 
the bench at room temperature to solidify. Using template and cutter, a 
rosette of six peripheral wells and central well were cut in the agar, and 
then the plugs were carefully removed. 
2. 8. 1. 3 Method of examination of the tested sera using AGPT test: 
 A method described by the OIE (2004) was used with some 
modifications. A volume of 0.025 ml of tested sera was added in the 
peripheral well and the antigen which was mixed with solution of 
sodium deoxycholate (Appendix 1.3) was added in the central well. Then 
the plates were incubated at 37o C in a humidity chamber,. The plates 
were examined daily for precipitation line for 48 hours. 
2. 8. 2 Hemagglutination (HA) and hemagglutination inhibition (HI) 
tests:   
2. 8. 2. 1 Preparation of 1% RBCs suspension: 
Three ml of blood were collected from the wing vein of healthy 
chicken in Alsever solution (App 1.6). The blood was placed into sterile 
tube and 2 ml of normal saline was added to the RBCs, and then 
centrifuged at 1000 rpm for 5 minutes, the supernatant was discarded 
and 5ml of sterile normal saline was added to the RBC pellets, mixed 
and centrifuged at 1000rpm for 5 minutes. This procedure was repeated 
three times. Then 1% RBCs suspension was made for use in HA and HI 
test. 
2. 8. 2. 2 Hemagglutination (HA) test: 
Volumes of 0.025 ml PBS were placed in each well of U–shaped 
microtitre plates with the aid of multichannel pipette. Two-fold serial 
dilution of the virus was made. Volumes of 0.025 ml of 1% suspension 
of RBCs were added to each well. The test was read after 30 minutes 
incubation at room temperature. The HA titer was reciprocal of the last 
dilution which completely agglutinate the RBCs. The test was done to 
determine the titer of avian influenza antigens (H5N1 and H7N3).  
2. 8. 2. 3 Hemagglutination inhibition test: 
2. 8. 2. 3. 1 Preparation of 4HA unit of the virus:  
HA test was made on undiluted influenza antigen (H5N1, H7N3) 
which propagated in the emboyronated eggs. The last well that give 
complete HA was considered one HA unit and the previous well 
considered the 2HA and accordingly, the 4 HA unit were accurately 
calculated. The virus suspension was then diluted to contain 4HA unit 
per 0.025 ml. 
2. 8. 2. 3. 2 Method of Hemagglutination inhibition test: 
According to Allan et al (1978) Volumes of 0.025 ml PBS (App 
1.2) were added to each well of U- shaped microtitre plates. Row H was 
left as control negative. Volumes of   0.025 ml of control sera were 
added in the first well of row A and the test sera were added in the other 
rows.  Two fold serial dilutions of the sera were made across the plates, 
and then 0.025 ml of 4HA unit of influenza virus was added to each 
well. The plates were shaken then left for 30 minutes at room 
temperature for antigen- antibody reaction to take place. Volumes of 
0.025 ml of 1% RBCs were then added to each well. The plates were 
read after 30 minutes at room temperature. The HI titer was the last 
dilution of the serum that inhibits hemagglutination.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER THREE 
3. Results 
3.1 Propagation of AI viruses: 
 3.1.1 Hemagglutination test (HA): 
Infected allantoic fluid  harvested from embryo which were 
inoculated with  H5N1 and H7N3 antigens  agglutinated 1% RBCs and  
gave titer ranged between 26 – 28 to H5N1 and 25 – 27 to                         
H7N3 antigens when tested by HA test. Both antigens were inhibited by 
known HIS in HI test. 
3.2 Hyperimmune sera (HIS): 
3.2.1 Pre inoculation sera: 
The sera collected from chicks before inoculation with H5N1 and 
H7N3 antigens gave no precipitation bands against H5N1antigen mixed 
with a soluation of sodium deoxycholate (App 1.3) when tested by agar 
gel immunodiffusion test. The same sera when tested by HI against 
H5N1 and H7N3 antigens, gave negative result. 
3.2.2 Post inoculation sera: 
 The sera collected at weekly interval from chicks which were 
inoculated with H5N1 and H7N3 gave strong precipitation lines between 
the antigen of   H5N1  mixed with a soluation of sodium deoxycholate 
(1.3)  in the central well and sera in peripheral wells when tested by agar 
gel immunodiffusion test. The same sera were tested by HI to determine 
the Abs titer raised against H5N1 and H7N3 antigens. The results are 
summarized in Table 2 and   Figure 1.  
 Table 2:  Antibody titer in the HIS when tested by HI test against H5N1 
and H7N3 antigens. 
  
Titer of Abs (H7N3) Titer of Abs (H5N1) 
Date of collection 
0 0 Week 0 
24 80 Week 1 
64 96 Week 2 
384 768 Week 3 
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3.3 Collection of blood samples for the serological survey: 
A total of 200 blood samples were collected, which consisted of 
190 sera collected  from chicken from different farms in Khartoum state( 
73 blood samples from broiler chicken and 117 blood samples from layer 
chicken) (Table 3), and 10 sera collected from poultry laborers in the 
same farms. 
 
Table 3: Type of chicken and the number of samples collected.    
Number of samples Type of chickens 
73 Broiler chickens 
117 Layer chickens 
190 Total 
 
 
 
 
 
 
 
3.4 Agar gel immune diffusion test(AGID): 
3.4.1 Propagation of AI viruses on chorioallantoic membrane 
(CAM):                                                  
Hemorrhage, edema and thickness were observed on harvested 
CAMS after inoculation of AI antigen (H5N1). Prepared antigen gave 
strong precipitation line when tested against known HIS. 
3.4.2 Serological Survey for AI antibodies in chickens using AGID : 
One hundred and ninety sera were collected from broiler and layer 
chickens and ten sera collected from poultry laborers in these farm were 
tested by AGID to investigate the presence of AI antibodies.  
Table 4 shows that 107 sera out of 190 (56.3%) were positive. 
Table 5 Shows that 7 sera out of 10 (70%) were positive for the sera 
collected from humans. Table 6 shows that 51 sera out of 73(69.9) from 
broiler chicken were positive and 56 sera out of 117(47.9) from layer 
chicken were positive (Figure 2). 
Table 4:   Results of testing chickens sera using AGID test 
AGID +ve( % ) Number of samples 
10 7(56.3) 190 
 
Table 5: Results of AGID test for sera collected from poultry 
laborers. 
AGID +ve (%) No. of samples 
7(70) 10 
Table 6: Results of testing sera collected from broiler and layer 
chickens using AGID. 
 
AGID +ve (%) No of samples Type of chicken 
51(69.9) 73 Broiler 
56(47.9) 117 Layer 
107(56.3) 190 Total 
 
The prevalence of avian influenza Abs in layer chicken was 61.8% 
and 35.5% in Bahry and Khartoum areas, respectively (Table 7). 
Prevalence of avian influenza Abs in Broiler chicken was 73.3% and 
64.3%  in Bahry and Omdurman areas, respectively (Table 9). 
There was strong relationship (X2 = 8.100, P > 0.004) between 
prevalence of avian influenza in layer chicken in Bahry and Khartoum 
areas (Figure3). 
A strong correlation was recorded between prevalence of avian 
influenza in Broiler chicken in Bahry and Omdurman Area.(X2= 9.656, 
P> 0.002)(Figure 4). 
 
Fi
gu
re
 (2
): 
R
es
ul
ts
 o
f t
es
tin
g 
se
ra
 c
ol
le
ct
ed
 fr
om
 b
ro
ile
r a
nd
 la
ye
r c
hi
ck
en
 in
 K
ha
rt
ou
m
 S
ta
te
 u
si
ng
 
AG
ID
.
02040608010
0
12
0
14
0
Br
oi
le
r
La
ye
r
ty
pe
 o
f c
hi
ck
en
A
G
ID
 +
ve
 (%
)
N
o 
of
 s
am
pl
es
Table 7: Results of AGID test in sera collected from Layer chickens. 
AGID+ ve (%) No of samples Location 
34(61.8) 55 Bahry 
22(35.5) 62 Khartoum 
56(47.9) 117 Total 
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Table 8: Results of AGID test in sera collected from Layer chickens 
according to  poultry farms.   
AGID + ve( %) No. of samples Location 
12 (52.2) 23 Bahry (Farm A1) 
22 (68.8) 32 Bahry (Farm A2) 
1 5 (68.2) 22 Khartoum (Farm E ) 
2 (10) 20 Khartoum ( Farm K1) 
5 ( 25) 20 Khartoum (Farm K2) 
5 6 (47.9) 117 Total 
A: El halfaia. 
E: El Remeyla. 
K: El Klakla. 
 
Table 9: Results of AGID test in sera collected from Broiler chickens 
AGID + ve (%) No. of samples Location 
33(73.3) 45 Bahry 
18(64.3) 28 Omdurman 
51(69.9) 73 Total 
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Table10: Results of AGID test in sera collected from Broiler 
chickens according to the poultry farms.   
AGID+ve (%) No. of samples Location 
23 (95.8) 24 Bahry  (FarmS1) 
10 (47.6) 21 Bahry (FarmS2) 
18 (64.3) 28 Omdurman 
51 (69.9) 73 Total 
S: Shambat 
3.5 Hemagglutination inhibition test: 
The HI test was applied to the sera collected from layer and broiler 
chickens which were positive by agar gel immunodiffusion test using 
H5N1 and H7N3 antigens. 
Table 11 . Shows the results of sera collected from layer chicken 
using H7N3 and H5N1; 14 sera out of 34(41.2) were positive from 
Bahry area and 4 sera out of 22 (18.2) were positive from Khartoum area 
using H7N3 antigen. When the same sera were tested against H5N1 
antigen the results showed that there was no Abs detected in Bahry area. 
In Khartoum area the results showed that one serum sample was positive 
in farm E. There was no relationship(X2 = 3.238, P > 0.072) between 
prevalence of avian influenza in layer chickens in Bahry and Khartoum 
area using HI test against H7N3. (Figure 5).  
Table 13 showed the results of broiler chickens, 3 sera out of 
33(9.1%) were positive from Bahry area using H7N3, when the same 
sera were tested against H5N1 they gave negative results. There was no 
Abs were detected against H7N3 and H5N1 from Omdurman area.  
There was no association recorded between prevalence of avian 
influenza in Broiler chickens in Bahry and Omdurman area against 
H7N3 using HI test. (X2= 1.739, P > 0.187)(Figure 6).   
Table 15: shows the results of sera collected from poultry laborers, 
4 sera out of 7(57.1%) were positive to H7N3 antigen using HI test. The 
sera when tested against H5N1 gave negative result.  
 
 
Table 11: Results of HI test using sera collected from Layer chickens  
Using H7N3 antigen and H5N1 antigens. 
HI positive (%) of 
H5N1 
HI positive (%) 
of H7N3 AGID positive Location 
0 14(41.2) 34 Bahry 
1(5.4) 4(18.2) 22 Khartoum 
1(1.8) 18(32.1) 56 Total 
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Table 12: Results of HI test using sera collected from Layer chickens 
according to poultry farms using  H7N3 and H5N1 antigens.  
HI positive  
(%) of 
H5N1 
HI positive  
(%) of 
H7N3 
AGID 
positive Area 
0 8 (66.7) 12 Bahry(Farm A1) 
0 6(27.3) 22 Bahry(Farm A2) 
1(6.7) 0 15 Khartoum (Farm E) 
0 0 2 Khartoum (Farm K1) 
0 4(80) 5 Khartoum (Farm K2) 
1(1.8) 18(32.1) 56 
Total 
 
 
 
 
Table 13: Results of HI test in sera collected from Broiler chickens 
using H7N3 and H5N1 antigens. 
HI +ve(%) of 
H5N1 
HI +ve(%) of 
H7N3 AGID positive Location 
0 3(9.1) 33 Bahry 
0 0 18 Omdurman 
0 3(5.9) 51 Total 
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Table14: Results of HI test in sera collected from Broiler chickens 
according to  poultry farms and age using of H7N3 and H5N1 
antigens. 
HI+ve (%) 
of H5N1 
HI+ve 
(%) of 
H7N3 
AGID 
positive Area 
 0 3(13.0) 23 Bahry (Farm S1) 
 0 0 10 Bahry (Farm S2) 
0 0 18 Omdurman 
 0 3 (5.9) 51 Total 
 
 
 
 
Table 15: Results of HI test from sera collected from poultry 
laborers using H7N3 and H5N1 antigens. 
HI +ve (%) AGID + ve 
4(57.1) 7 
 
Table 16: The titer of Abs against  H7N3 in the sera collected from 
chickens using HI test.  
8log2 7log2 6log2 5log2 4log2 3log2 2log2 Type of chickens 
_ _ _ 1 2 _ _ Broiler chickens 
2 4 5 3 4 _ _ Layer chickens 
 
 
 
 
 
Table 17: The titer of Abs against  H7N3 in the sera collected from 
humans using HI test.  
 
8 log2 
 
7 log2 
 
6 log2 
 
5 log2 
 
4 log2 
 
3 log2 
 
2 log2 
Type 
_ _ 1 1 2 _ _ Human 
 
 
 
CHAPTER FOUR 
4. Discussion 
 
Avian influenza is an infectious disease of birds caused by type A 
strains of the influenza virus, the disease occurs worldwide (WHO, 
2006).Now all the world is warried from the outbreaks of AI and the 
zoontic nature of the virus. So the study was carried out to investigate 
the presence of AI antibodies in layer and broiler chickens and few 
numbers of humans in contact with them in Khartoum state. 
A total of 190 serum samples were collected from chickens (73 
sera from broiler and 117 sera from layer chickens) and 10 sera from 
poultry laborers in these farms. The serum samples were collected during 
March and April in 2006.  
All the sera were tested by AGID test to investigate the presence 
of AI virus group specific antibodies in Khartoum state. The results 
showed that 107 out of 190 (56.3%) chickens' sera were positive. The 
result of sera collected from poultry laborers revealed that 7 sera out of 
10(70%) were positive. The HI test was applied to the positive sera using 
H7N3 and H5N1 antigens and the results showed that 21 out of 107 
(19.6%) sera collected from chickens were positive and 4 sera out of 7 
(57.1%) collected from poultry laborers were positive when tested 
against H7N3 antigen. The same sera were tested against H5N1 and the 
results showed that one serum sample was positive from chicken and no 
Abs to H5 antiserum was detected in humans.    
AGID is a group-specific test for antibody, it is relatively useful 
on a flock basis for serology for LPAI but of limited use for HPAI 
strains where mortality is high .All influenza A viruses has antigenically 
similar nucleocapsid and antigenically similar matrix antigens. This fact 
enables the presence or absence of antibodies to any influenza A virus to 
be detected by AGID tests. Concentrated virus preparations, as described 
in (OIE, 2004), contain both matrix and nucleocapsid antigens; the 
matrix antigen diffuses more rapidly than nucleocapsid antigen. AGID 
tests have been widely and routinely used to detect specific antibodies in 
chicken and turkey flocks as an indication of infection (OIE, 2004). 
The AIA virus antibodies were detected in two types of chickens 
(layer and broiler) in Khartoum state using AGID test. The 
seroprevalence of AI antibodies in layer chickens was 61.8 % and 35.5% 
in Bahry and Khartoum area respectively. In broiler chickens the 
seroprevalence of AI antibodies was 73.3% from Bahry area and 64.3% 
from Omudurman area. Similarly, Manal (1998) reported that 18 out of 
100 (18%) sera were positive from chicken sera obtained from CVRL in 
Soba using AGID test. Huda (2006) conducted a study to standardize the 
AGID and applicated the standardized method for two hundred sera 
collected from humans and chickens. She reported that the mean sero-
positivity of antibodies to AI A virus using the standard AGID procedure 
was 32% out of 100 chicken sera. In this study the prevalence rates is 
much higher than that obtained by Manal (1998) and Huda (2006) which 
indicated the increasing of the spread of AIA virus infection in 
Khartoum. The results of sera collected from poultry laborers showed 
that 7 sera out of 10 (70%) were positive. Similarly Huda (2006) 
reported that the prevalence of AIA antibodies in 100 sera collected from 
humans in Khartoum state was 24%. The prevalence of antibodies in this 
study was much lower because the number of sample is very low.  
The HI test is the subtype- specific test recommended. It is 
sensitive and specific when epidemiologically appropriate antigen is 
used. It can be used for monitoring the response to vaccination and 
where birds survive infection (e.g. with LPAI or HPAI in ducks) to 
monitor circulation of virus (FAO, 2004). The HI test is extremely 
reliable, provided reference antiserum is available to all subtypes. HI 
assay is remaining the test of choice for WHO global influenza 
surveillance (WHO, 2002). 
The HI test was applied to the positives sera by AGID test to sub 
type the Abs using H5 and H7 antigens. The results of the sera collected 
from layer chickens when tested against H7N3 antigen showed that 14 
serum samples out of 34 were positive from Bahry area and 4 sera out of 
22   were positive from Khartoum area. The results showed that the 
prevalence of Abs is higher in Bahry area compared to Khartoum area. A 
total of 51 serum samples from broiler chickens tested against H7 
antigen, only 3 serum samples were positive from Bahry area and no 
antibodies were detected in Omdurman area. This result agreed with 
Samar (2006) who reported that  antibodies were detected in the sera 
collected from chickens in Shambat area with 21 serum samples out of  
100 (21%)  positive when the HI test was used against  H7 antigen.   
Spackman, (2005) reported that H7N3 virus was detected on a 
commercial chicken breeder farm in British Columbia and Canada. 
Capua et al (2002) also reported that an epidemic of LP H7N3 influenza 
virus was detected in Northern Italy in farms that intensively rear turkeys 
and chickens.  
 
All the sera from layers and broiler chickens when tested against 
H5 antigen revealed that only one serum sample was positive from layer 
chickens in Khartoum area. This agreed with Samar (2006) who reported 
that only two serum samples out of 100 were positive from chickens. 
Wegdan and Kheir (2007) isolated the H5N1 from 6 farms in Khartoum 
state and 2 farms in AlGazeera state. Similarly, OIE (2006) reported that 
AIA virus subtype H5N1 was detected in Sudan in 19April 2006 in 
outbreaks in Khartoum and AlGazeera state. The results of the sera 
collected from poultry laborers showed that 4 sera out of 7 (57.1%) were 
positive when tested against H7N3 antigen, this result agreed with Samar 
(2006) who also reported that antibodies against AI virus type H7N3 
were detected in 100 human's sera and the results revealed that 15 sera 
out of 100 (15%) were positive. In this study the prevalence of Abs is 
much lower than the results obtained by Samar; this was probably due to 
low number of samples. A report published on Medical News Today in 
(2006) reported that one of the poultry workers who worked at Watford 
Lodge Farm in Norfolk, England, has become infected with the H7N3 
Bird Flu virus strain and this indicate that H7N3 can be transmitted to 
poultry laborers.  
Hence the results of this study showed that the AIA virus type H7 
was detected in the sera collected before the 2006 outbreak of H5N1 in 
Sudan and this indicate that H7 was circulating in Khartoum state before 
the H5N1 outbreak in April 2006.    
  
 
 
 
CONCLUSION AND RECOMMENDATIONS  
The present work has confirmed for the first time the circulation of the 
avian influenza viruses type H7 in chickens and poultry laborers in 
Sudan. 
It is therefore recommended that further studies should be done to 
explore the role of H7 and  what the control measures must be taken 
before the outbreak occurs because H7 may be inverted to high 
pathogenic by mutation, beside that H5N1 outbreak must be consider. 
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APPENDICES 
 
1. Reagent: 
1.1. Normal Saline (NS):  
Stock solution of 0.85% (W/V) NaCl was prepared in DDW and 
autoclaved at 121°C for 20 minutes. 
1.2 Phosphate buffer saline (PBS) PH 7.4: 
Soluation A: 
Nacl                                 8.0 gm                                                            
K CL                               0.20 gm 
Na2 HPO4                       1.15 gm  
K H2PO4                         0.20 gm  
DW                                100 ml 
Soluation B: 
CaCL2                           0.10gm                                          
DW                               100ml         
Soluation C: 
MgCL26H2O                  0.10gm                                                   
sDW                             100ml                                                               
 
 
Soluation A , B , C , were prepared in separated container, autoclaved at 
121°C for 15 minutes and left to cool then soluation B and C were added 
to soluation A and stored  
 at 4°C. 
1.3 Sodium deoxycholate soluation: 
Sodium deoxycholate                 2.00 gm  
Distilled water                           100 ml  
1.4 Ethanol 70%  
Ethanol                                     70 ml  
Distilled water                         30 ml 
1.5 Sodium Hydroxide Solution:  
NaoH                                    45gm 
DW                                       300ml 
2. Preparation of agar gel: 
Purified agar                       1.6gm 
NaCl                                   8.00gm 
Normal saline                      100 ml 
3. AL severs's solution: 
Dextrose                             20.5gm 
NaCl                                   4.2gm 
Sodium citrate                    8.0gm 
Citric acid                           0.55gm 
The mixture was completed to one liter with distilled water and 
autoclaved at 115°C for 10 minutes. 
4. Antibiotics:  
4.1 Penicillin-Streptomycin Solution: 
 One gram of streptomycin powder and the contents of 2 vials 
of penicillin (1000000 IU/vial) were dissolved in 10 ml of sterile 
deionizer distill water (DDW) to give solution contained 100 mg 
streptomycin and 200000 IU penicillin per ml. The solution was kept 
at -20ºC. 
 4.2 Fungizon Solution: 
 The content of one vial of fungizon (50000 µg) was 
dissolved in 10 ml of sterile DDW and kept at 4ºC 
 
 
 
 
 
    
     
 
 
